David Francis Carroll Iveric Bio, Inc. (ISEE) insider trading activity

ISEE Quotes by TradingView

David Francis Carroll is SVP, Chief Financial Officer of IVERIC bio, Inc.. Currently has a direct ownership of 0 shares of ISEE, which is worth approximately $0. The most recent transaction as insider was on Jul 11, 2023, when has been sold 44,152 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

David Francis Carroll Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 11 2023
SELL
Sale (or disposition) back to the issuer
-
44,152 Reduced 100.0%
0 Common Stock
Jun 26 2023
SELL
Bona fide gift
-
24,320 Reduced 35.52%
44,152 Common Stock
May 01 2023
SELL
Open market or private sale
$2,352,040 $37.04 p/Share
63,500 Reduced 48.12%
68,472 Common Stock
May 01 2023
BUY
Exercise of conversion of derivative security
$178,435 $2.81 p/Share
63,500 Added 32.49%
131,972 Common Stock
Apr 24 2023
SELL
Open market or private sale
$1,455,245 $30.21 p/Share
48,171 Reduced 41.3%
68,472 Common Stock
Apr 24 2023
BUY
Exercise of conversion of derivative security
$69,847 $1.45 p/Share
48,171 Added 29.23%
116,643 Common Stock
Apr 21 2023
SELL
Open market or private sale
$54,870 $30.0 p/Share
1,829 Reduced 2.6%
68,472 Common Stock
Apr 21 2023
BUY
Exercise of conversion of derivative security
$2,652 $1.45 p/Share
1,829 Added 2.54%
70,301 Common Stock
Jan 03 2023
SELL
Open market or private sale
$72,256 $20.06 p/Share
3,602 Reduced 5.0%
68,472 Common Stock
Jan 02 2023
BUY
Exercise of conversion of derivative security
-
8,750 Added 10.83%
72,074 Common Stock
Dec 19 2022
SELL
Open market or private sale
$121,983 $21.51 p/Share
5,671 Reduced 8.22%
63,324 Common Stock
Dec 18 2022
BUY
Exercise of conversion of derivative security
-
14,375 Added 17.24%
68,995 Common Stock
Dec 13 2022
SELL
Open market or private sale
$107,172 $21.73 p/Share
4,932 Reduced 8.28%
54,620 Common Stock
Dec 12 2022
SELL
Open market or private sale
$82,708 $20.96 p/Share
3,946 Reduced 7.74%
47,052 Common Stock
Dec 12 2022
BUY
Exercise of conversion of derivative security
-
12,500 Added 17.35%
59,552 Common Stock
Dec 09 2022
BUY
Exercise of conversion of derivative security
-
10,000 Added 16.39%
50,998 Common Stock
Apr 05 2022
SELL
Open market or private sale
$89,043 $19.01 p/Share
4,684 Reduced 10.44%
40,166 Common Stock
Apr 05 2022
BUY
Exercise of conversion of derivative security
$6,792 $1.45 p/Share
4,684 Added 9.46%
44,850 Common Stock
Apr 04 2022
SELL
Open market or private sale
$767,644 $18.75 p/Share
40,941 Reduced 50.48%
40,166 Common Stock
Apr 04 2022
BUY
Exercise of conversion of derivative security
$29,458 $1.45 p/Share
20,316 Added 20.03%
81,107 Common Stock
Apr 01 2022
SELL
Open market or private sale
$36,448 $17.0 p/Share
2,144 Reduced 3.41%
60,791 Common Stock
Mar 25 2022
SELL
Open market or private sale
$285,459 $17.02 p/Share
16,772 Reduced 21.04%
62,935 Common Stock
Mar 25 2022
BUY
Exercise of conversion of derivative security
$24,306 $1.45 p/Share
16,763 Added 17.38%
79,707 Common Stock
Mar 18 2022
SELL
Open market or private sale
$196,537 $17.0 p/Share
11,561 Reduced 15.52%
62,944 Common Stock
Mar 18 2022
BUY
Exercise of conversion of derivative security
$11,944 $1.45 p/Share
8,237 Added 9.96%
74,505 Common Stock
DFC

David Francis Carroll

SVP, Chief Financial Officer
Parsippany, NJ

Track Institutional and Insider Activities on ISEE

Follow IVERIC bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ISEE shares.

Notify only if

Insider Trading

Get notified when an Iveric Bio, Inc. insider buys or sells ISEE shares.

Notify only if

News

Receive news related to IVERIC bio, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ISEE